Testing a new PET scan tracer for brain tumors
Original title: MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test in a small number of people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a new tracer that may help PET scans show brain tumors.
Who this trial is for. This is the first test in people of a PET scan tracer called MeFAMP. It includes healthy volunteers, people with a brain tumor called high grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, and people whose cancer spread to the brain.
Where it stands. This trial has not reported results. It is measuring how safe the tracer is. It is also measuring the radiation dose people get. The team also wants to see if the scan can tell a growing tumor from changes caused by radiation. The answers are not in yet.
What this means, and what it doesn't
What it could mean: If the scan works, it may help doctors tell tumor growth from radiation effects. Nobody knows yet if it does. Someone who thinks they fit can ask their care team about this study.
What it doesn't mean: This does not mean the scan is proven. A trial is a test, not care your own doctor can give you. Being in one is not a promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, August 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.